However, IGF2BP3 displays unusually elevated expression in several cancers, including cervical, gastric, breast, and colorectal, and is closely linked to tumor aggressiveness, metastasis, and unfavorable prognosis [12]. Here, IGF2BP3 is linked to neoplasm.